Hohlfeld R - Search Results

1

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.

Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, Wegner F, Hohlfeld R, Straeten V, Limmroth V, Weber T, Hermsen D, Kleinschnitz C, Hartung HP, Wattjes MP, Svenningson A, Major E, Olsson T, Kieseier BC, Adams O. Warnke C, et al. Among authors: hohlfeld r. Ann Neurol. 2014 Dec;76(6):792-801. doi: 10.1002/ana.24153. Epub 2014 May 8. Ann Neurol. 2014. PMID: 24729444 Free PMC article.

2

Myasthenia gravis: discontinuation of long-term azathioprine.

Michels M, Hohlfeld R, Hartung HP, Heininger K, Besinger UA, Toyka KV. Michels M, et al. Among authors: hohlfeld r. Ann Neurol. 1988 Dec;24(6):798. doi: 10.1002/ana.410240619. Ann Neurol. 1988. PMID: 3207364 No abstract available.

3

[Interferon-beta in treatment of relapsing multiple sclerosis].

Hartung HP, Hohlfeld R. Hartung HP, et al. Among authors: hohlfeld r. Nervenarzt. 1994 Feb;65(2):139-45. Nervenarzt. 1994. PMID: 8164769 Clinical Trial. German. No abstract available.

4

[Interferon-beta 1a in therapy of relapsing-remitting multiple sclerosis].

Hartung HP, Hohlfeld R. Hartung HP, et al. Among authors: hohlfeld r. Nervenarzt. 1997 Jun;68(6):525-7. doi: 10.1007/s001150050157. Nervenarzt. 1997. PMID: 9312688 Review. German. No abstract available.

5

[Formation of neutralizing antibodies in therapy of multiple sclerosis with interferon beta-1b. Practical procedure in suspected therapeutic failure].

Walther EU, Dang T, Hartung HP, Hohlfeld R. Walther EU, et al. Among authors: hohlfeld r. Nervenarzt. 1997 Dec;68(12):935-9. doi: 10.1007/s001150050219. Nervenarzt. 1997. PMID: 9465334 Review. German.

6

Multiple sclerosis: side effects of interferon beta therapy and their management.

Walther EU, Hohlfeld R. Walther EU, et al. Among authors: hohlfeld r. Neurology. 1999 Nov 10;53(8):1622-7. doi: 10.1212/wnl.53.8.1622. Neurology. 1999. PMID: 10563602 Review.

7

Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients.

Farina C, Vargas V, Heydari N, Kümpfel T, Meinl E, Hohlfeld R. Farina C, et al. Among authors: hohlfeld r. J Neuroimmunol. 2002 Feb;123(1-2):188-92. doi: 10.1016/s0165-5728(01)00490-8. J Neuroimmunol. 2002. PMID: 11880163

8

[Antegren (natalizumab). A promising new approach to therapy of multiple sclerosis].

Kümpfel T, Heydari N, Hohlfeld R. Kümpfel T, et al. Among authors: hohlfeld r. Nervenarzt. 2002 Jun;73(6):552-5. doi: 10.1007/s00115-002-1314-3. Nervenarzt. 2002. PMID: 12243004 German.

9

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.

Ziemssen T, Kümpfel T, Klinkert WE, Neuhaus O, Hohlfeld R. Ziemssen T, et al. Among authors: hohlfeld r. Brain. 2002 Nov;125(Pt 11):2381-91. doi: 10.1093/brain/awf252. Brain. 2002. PMID: 12390966

10

A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS.

Clanet M, Radue EW, Kappos L, Hartung HP, Hohlfeld R, Sandberg-Wollheim M, Kooijmans-Coutinho MF, Tsao EC, Sandrock AW; European IFNbeta-1a (Avonex) Dose-Comparison Study Investigators. Clanet M, et al. Among authors: hohlfeld r. Neurology. 2002 Nov 26;59(10):1507-17. doi: 10.1212/01.wnl.0000032256.35561.d6. Neurology. 2002. PMID: 12451189 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters